SurgiBox Partnered with Ondatec Medical Announcement SurgiBox Inc., a leading medical technology company known for its excellent surgical services, has entered into a partnership agreement with Ondatec Medical, a popular medical device provider in Turkey. This partnership strongly ref...
Pelthos Therapeutics Finalized the Merger Agreement with Channel Therapeutics Announcement Pelthos Therapeutics Inc., a global biopharmaceutical company known for marketing innovative therapeutic products for patients in need, is wrapping up the previous merger agreement with CHRO Merger Sub Inc...
Lixte Biotechnology Holdings Inc.'s Finalization of Securities in the Market Announcement Lixte Biotechnology Holdings, Inc., a pharmaceutical company, closed its private placement with valuable investors for the sale and purchase of $5.0 million of shares of common stock, a series B convertible...
Bluebird, a Center of Attraction What makes a popular equity firm approach a small biopharma firm? The Carlyle Group, along with SK Capital partner, intends to buy bluebird Bio for under $50 million. The Carlyle Group, with its $453 billion in assets under management, and SK Capital partner of $...
Which Company is Investing in Improving a Specific Treatment? Kardium Inc., a founder of the ‘Globe® Pulsed field system’, which is an innovative treatment for atrial fibrillation (AF), has increased its investment to US$250 million. The financing round consists of new investors s...
Gilead's Chances Peak Until GSK’s Response to the Competition Announcement Gilead’s new PreP drug, ‘Yeztugo’, is said to be reaching sales of $4.5 billion, if GSK doesn’t have anything to say about its Apretude medication. Gilead is strengthening its position in the...
BioVersys and Shionogi Joined Forces to Accelerate Research and Development Announcement BioVersys AG, a biopharmaceutical company known for its excellent research and development of antibacterial products for severe infections caused by multidrug-resistant (MDR) bacteria, has signed an exclusiv...
Rinri’s Clinical Trial Application, a First Approval of the Month Image Credits: Hearing Health & Technology Matters Announcement Rinri Therapeutics, a global company aiming to bring a transformation and development in sensorineural hearing loss (SNHL) with regenerative cell therapy, ...
Another Innovation to be Launched at ENDO 2025 Image Credits: The Manila Times Announcement Crinetics Pharmaceuticals, Inc. is ready to showcase eight abstracts from its clinical development programs, and its oral presentations involve an investigational drug candidate, atumelnant, and PALSONIF...
MaxCyte ExPERT Platform in Japan Image Credits: Galveston Country Daily News Announcement The PHC corporation, a biomedical division subsidiary of PHC Holdings Corporation, has entered an agreement with MaxCyte Inc. for the distribution of the MaxCyte ExPERT platform in Japan. In June, Singapor...
